Profil
Yuan Cui is currently a Partner at K2 Partners.
Prior to this, from 2018 to 2020, Mr. Cui worked as a Director at NKD Pharma Co., Ltd.
Postes actifs de Yuan Cui
| Sociétés | Poste | Début |
|---|---|---|
K2 Partners
 K2 Partners Investment ManagersFinance K2 Partners is a venture capital firm founded in 2010, headquartered in Beijing. | Private Equity Investor | - |
Anciens postes connus de Yuan Cui
| Sociétés | Poste | Fin |
|---|---|---|
NKD Pharma Co., Ltd.
 NKD Pharma Co., Ltd. Pharmaceuticals: MajorHealth Technology NKD Pharma Co., Ltd. engages in the provision of entrusted research and development services, and independent project research and development services. Its entrusted research and development services cover pharmaceutical research, non-clinical research, and clinical research services for pharmaceutical companies and pharmaceutical research and development investment companies. Its independent project research and development services encompass generic drug, medical devices, and special medical food development services. The company was founded by Peng Chen, Xiu Mei Tao, Chun Peng Wang, and Ke Min Li on July 23, 2013 and is headquartered in Beijing, China. | Directeur/Membre du Conseil | 01/05/2020 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
K2 Partners
K2 Partners Investment ManagersFinance K2 Partners is a venture capital firm founded in 2010, headquartered in Beijing. | Finance |
NKD Pharma Co., Ltd.
NKD Pharma Co., Ltd. Pharmaceuticals: MajorHealth Technology NKD Pharma Co., Ltd. engages in the provision of entrusted research and development services, and independent project research and development services. Its entrusted research and development services cover pharmaceutical research, non-clinical research, and clinical research services for pharmaceutical companies and pharmaceutical research and development investment companies. Its independent project research and development services encompass generic drug, medical devices, and special medical food development services. The company was founded by Peng Chen, Xiu Mei Tao, Chun Peng Wang, and Ke Min Li on July 23, 2013 and is headquartered in Beijing, China. | Health Technology |
